Back
ResMed, Inc. Vs. Novanta, Inc. Industry Stock Comparison
Buy
56
RMD
ResMed, Inc.
Last Price:
$250.97
Seasonality Move:
4.2%
Buy
52
NOVT
Novanta, Inc.
Last Price:
$128.71
Seasonality Move:
13.22%
Buy
56
ResMed, Inc. (RMD)
is a Buy
Is ResMed, Inc. a Buy, Sell or Hold?
-
The current ResMed, Inc. [RMD] share price is $250.92. The Score for RMD is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
RMD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Novanta, Inc. (NOVT)
is a Buy
Is Novanta, Inc. a Buy, Sell or Hold?
-
The current Novanta, Inc. [NOVT] share price is $128.70. The Score for NOVT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
NOVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RMD Stock Price Chart
What is ResMed, Inc.'s stock price today?
-
The ResMed, Inc. share price today is $250.92The current trend is relatively stagnant and RMD is experiencing buying pressure, which is a positive indicator for future bullish movement.
NOVT Stock Price Chart
What is Novanta, Inc.'s stock price today?
-
The Novanta, Inc. share price today is $128.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOVT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 55.37 | Buy |
| Chaikin Money Flow: | 404638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (243.74 - 251.6) | Buy |
| Bollinger Bands (100): | (247.59 - 276.11) | Sell |
NOVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.37 | Buy |
| Relative Strength Index (14 RSI): | 63.7 | Buy |
| Chaikin Money Flow: | 439249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.87 - 123.49) | Buy |
| Bollinger Bands (100): | (105.66 - 122.64) | Buy |
RMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 245.66 | Buy |
| 20-day SMA: | 246.79 | Buy |
| 50-day SMA: | 248.84 | Buy |
| 200-day SMA: | 254.93 | Sell |
| 8-day EMA: | 247.13 | Buy |
| 20-day EMA: | 247.13 | Buy |
| 50-day EMA: | 251.11 | Sell |
| 200-day EMA: | 253.09 | Sell |
NOVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.8 | Buy |
| 20-day SMA: | 120.83 | Buy |
| 50-day SMA: | 116.87 | Buy |
| 200-day SMA: | 118.71 | Buy |
| 8-day EMA: | 122.72 | Buy |
| 20-day EMA: | 120.34 | Buy |
| 50-day EMA: | 117.28 | Buy |
| 200-day EMA: | 122.61 | Buy |
ResMed, Inc. Earnings Growth & RMD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $1.12 per share.
Novanta, Inc. Earnings Growth & NOVT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.45 per share.
ResMed, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novanta, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||